15 September 2020

ProBCI

There is a pressing need for predictive biomarkers to personalize bladder cancer treatment. Patients with bladder cancer will be prospectively recruited for the Prospective Bladder Cancer Infrastructure (ProBCI) with longitudinal assessments from primary diagnosis until death. This infrastructure has the following objectives:

  • Inform on the epidemiology of bladder cancer in the Netherlands and the treatment evolution landscape;
  • Facilitate the selection of eligible patients for specific intervention studies, thereby improving accrual rates;
  • Facilitate the identification of historical or concurrent control groups for future single arm intervention studies;
  • Validate the efficacy and safety of novel diagnostic and therapeutic approaches in a real-world patient population;
  • Evaluate the impact of bladder cancer treatment on patient reported outcomes;
  • Provide access to blood and tumor tissue of bladder cancer patients for biomarker discovery and validation studies and organoid culture.
  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud Biobank

Related news items


Control over Human Biomaterials Act [Wet zeggenschap lichaamsmateriaal] (Wzl)

19 July 2022

The Ministry of Health, Welfare and Sport (VWS) is currently preparing a Control over Human Biomaterials Act [Wet zeggenschap lichaamsmateriaal] (Wzl) which will serve in the future as a specific legal framework for the (further) use of body tissue for medical scientific research.

read more

Health-RI annual report

19 July 2022

Health-RI has presented the 2021 annual report. In this report they outline an overview of recent activities and results of the past year 2021 (in Dutch).

read more

SPIDI sub-biobank

19 July 2022

The SPIDI collection aims to assess the prognostic value of MRI-DWI (new form of MRI research) and biomarkers (brain-specific proteins in cerebrospinal fluid) in the first 24 hours after the occurrence of a spinal cord injury as a result of trauma.

read more

MyCoS sub-biobank

8 April 2022 The Radboud Biobank has added one new sub-biobank to the collection: MyCoS. read more